the role of molecular markers in patient selection for transplantation in myelofibrosis
Published 1 year ago • 104 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
2:57
selecting patients with myelofibrosis for allosct: molecular, patient & transplant-related factors
-
1:35
the role of allogeneic transplantation in myelofibrosis & patient eligibility for allosct
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:39
what are indicators of mpn progression?
-
1:46:07
hematology lecture
-
38:34
tracer: antigen-centric mhc recognition by a novel engineered protein platform
-
2:29
the measurement of molecular biomarkers to aid cll treatment
-
0:42
haploidentical transplant in argentina
-
1:53
classifying mpns with molecular genetic markers
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:09
heart transplantation in attr amyloidosis
-
3:40
master class in transplantation and hematology: highlights
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
2:23
the use of solid organ transplant in al amyloidosis
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
3:27
phenotypes and molecular markers indicating elevated risk of rt in patients with cll
-
1:09
using mrd and mutational analysis when selecting patients with t-all for transplantation
-
1:23
the value of mrd as a marker for disease eradication in aml